Documents

Discussions Technicals Forecast Seasonals

Theriva Biologics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Theriva Biologics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 11, 2025

Quarterly report10-Q

Earnings release8-K

Q1 2025

May 14, 2025

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 06, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 12, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 13, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 07, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 25, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 13, 2023

Quarterly report10-Q

Q2 2023

Aug 08, 2023

Quarterly report10-Q

Q1 2023

May 11, 2023

Quarterly report10-Q

2022

Q4 2022

Mar 30, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 11, 2022

Quarterly report10-Q

Q2 2022

Aug 11, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 16, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 16, 2022

Annual report10-K

2020

Q4 2020

Mar 04, 2021

Annual report10-K

2019

Q4 2019

Feb 20, 2020

Annual report10-K

2018

Q4 2018

Feb 27, 2019

Annual report10-K

2017

Q4 2017

Feb 22, 2018

Annual report10-K

2016

Q4 2016

Mar 02, 2017

Annual report10-K

2015

Q4 2015

Mar 10, 2016

Annual report10-K

2014

Q4 2014

Mar 16, 2015

Annual report10-K